Home / Recalls / RISING PHARMACEUTICALS / D-0005-2022

D-0005-2022 Class II Ongoing

Recalled by RISING PHARMACEUTICALS — East Brunswick, NJ

Recall Details

Product Type
Drugs
Report Date
October 13, 2021
Initiation Date
September 2, 2021
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,344 bottles

Product Description

Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816, Manufactured by: Aurex laboratories LLC, East Windsor, NJ 08520, NDC 16571-752-01

Reason for Recall

Labeling: Incorrect Instructions

Distribution Pattern

to be entered

Code Information

Lot # CB21024, Exp 2/2023

Other recalls by RISING PHARMACEUTICALS

  • D-0348-2023 Class II — Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Ri (February 15, 2023)
  • D-0573-2022 Class II — Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Onl (February 7, 2022)
  • D-1367-2020 Class III — Timolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topi (November 15, 2019)
  • D-1368-2020 Class III — Timolol Maleate Sterile Opthalmic Solution,USP 0.25%, 5 mL, Rx Only, For Topical (November 15, 2019)
  • D-1053-2019 Class II — Valsartan Tablets 80 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetri (March 7, 2019)
  • D-1054-2019 Class II — Valsartan Tablets 160 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetri (March 7, 2019)
  • D-1052-2019 Class II — Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetri (March 7, 2019)
  • D-1055-2019 Class II — Valsartan Tablets 320 mg USP, 90 tablet bottles, Distributed by: Acetris Health, (March 7, 2019)